A 64-year-old man with end-stage diabetic renal disease who developed delirium and generalized myoclonic movements after his first hemodialysis treatment. His cognitive function returned to baseline and the movements progressively disappeared within a week without desferrioxamine. Subsequent dialysis sessions were deliberately designed at a slower pace to minimize such occurrences.
Alberto J. Espay, MD, MSc, FAAN
CONTINUUM: Lifelong Learning in Neurology. 19(5, Movement Disorders):1264-1286, October 2013